CorFlow (@corflowinc) 's Twitter Profile
CorFlow

@corflowinc

CorFlow is developing a system that will be the first to detect and treat microvascular obstruction (MVO) in real-time.

ID: 1620430431802859522

linkhttps://corflow.com/ calendar_today31-01-2023 14:35:43

12 Tweet

17 Followers

45 Following

LSI - Life Science Intelligence™ (@lsintelligence) 's Twitter Profile Photo

5. CorFlow Therapeutics, Paul Mead, CEO → @CorFlowAG is developing a device that will diagnose microvascular obstructions (MVO) in real time during a PCI.

5. CorFlow Therapeutics, Paul Mead, CEO
→ @CorFlowAG is developing a device that will diagnose microvascular obstructions (MVO) in real time during a PCI.
CorFlow (@corflowinc) 's Twitter Profile Photo

Our CEO Paul Mead & co-founder Dr. Martin Rothman look forward to speaking at #LSI2023 about a unique technology addressing a major unmet need in #STEMI heart attack care & #MVO. Reach out if you would like to connect! #venturecapital #medtech #pharma #startup #cardiology

Our CEO Paul Mead & co-founder Dr. Martin Rothman look forward to speaking at #LSI2023 about a unique technology addressing a major unmet need in #STEMI heart attack care &  #MVO.  Reach out if you would like to connect! #venturecapital #medtech #pharma #startup #cardiology
CorFlow (@corflowinc) 's Twitter Profile Photo

We extend our appreciation to the diligent doctors and resident physicians who make continuous efforts to protect our health every day, including on this occasion of #NationalDoctorsDay. Thank you!

We extend our appreciation to the diligent doctors and resident physicians who make continuous efforts to protect our health every day, including on this occasion of #NationalDoctorsDay. Thank you!
CorFlow (@corflowinc) 's Twitter Profile Photo

We are Thrilled to Announce: MOCA I first in human Late Breaking Trial presented by Dr. Marco Valgimigli at #EuroPCR on Friday, May 19th. #STEMI #beyondPCI #unmetneed #interventionalcardiology #CorFlow #innovation #patientsfirst #medtech #startups

We are Thrilled to Announce: MOCA I first in human Late Breaking Trial presented by Dr. Marco Valgimigli at #EuroPCR on Friday, May 19th.  #STEMI #beyondPCI #unmetneed #interventionalcardiology #CorFlow #innovation #patientsfirst #medtech #startups
CorFlow (@corflowinc) 's Twitter Profile Photo

CorFlow is thrilled to have the opportunity to participate at the #EuroPCR event and looks forward to connecting with attendees throughout the duration of the conference. #Corflow #MVO #STEMI #BeyondPCI #Unmetneed #InterventionalCardiology #Innovation #PatientsFirst #Medtech

CorFlow is thrilled to have the opportunity to participate at the #EuroPCR event and looks forward to connecting with attendees throughout the duration of the conference.  #Corflow #MVO #STEMI #BeyondPCI #Unmetneed #InterventionalCardiology #Innovation #PatientsFirst #Medtech
CorFlow (@corflowinc) 's Twitter Profile Photo

Experience the groundbreaking MOCA I first-in-human Late Breaking Trial presented by Dr. Marco Valgimigli at #EuroPCR Friday, May 19th. Join us in person or remotely; we invite you to be part of this significant event. #MVO #STEMI #InterventionalCardiology PCRonline 🫀

Experience the groundbreaking MOCA I first-in-human Late Breaking Trial presented by Dr. Marco Valgimigli at #EuroPCR  Friday, May 19th.  Join us in person or remotely; we invite you to be part of this significant event. #MVO #STEMI #InterventionalCardiology  <a href="/PCRonline/">PCRonline 🫀</a>
CorFlow (@corflowinc) 's Twitter Profile Photo

CorFlow Announces Positive Data from the MOCA I First in Human Study Presented at EuroPCR 2023 - businesswire.com/news/home/2023…

CorFlow (@corflowinc) 's Twitter Profile Photo

The MOCA I study, presented by Dr. Valgimigli at #euroPCR2023, suggests that early diagnosis & targeted treatment for high-risk patients could lead to significant advancements in the field. Read full Press Release corflowinc.com/news PCRonline 🫀 #MVO #STEMI #unmetneed

The MOCA I study, presented by Dr. Valgimigli at #euroPCR2023, suggests that early diagnosis &amp; targeted treatment for high-risk patients could lead to significant advancements in the field. Read full Press Release corflowinc.com/news <a href="/PCRonline/">PCRonline 🫀</a> #MVO #STEMI #unmetneed
CorFlow (@corflowinc) 's Twitter Profile Photo

The CorFlow MOCA I Trial: learnings from the first-in-human direct measurement of microvascular obstruction in STEMI via PCRonline 🫀 pcronline.com/tiny/url/670940

CorFlow (@corflowinc) 's Twitter Profile Photo

Financing Round is complete. Our path to bring our unique technology for diagnosing and delivering therapies for MVO is set. Curious and want to see more?corflow.com/news

CorFlow (@corflowinc) 's Twitter Profile Photo

Its CoFi time! We are absolutely thrilled to announce the FDA approval of the MOCA II IDE pivotal trial and cannot wait to get sites up and recruiting in this landmark trial for CorFlow. Want to learn more about MVO and STEMI?corflow.com/wp-content/upl…